Table 3. Results of meta-analysis of the studies on comparison between CB-DOT and Family-based DOT, Workplace-based DOT and administered treatment in TB control.

Styles of Meta	No. Of studies	No. of participants	Variance between studies		Pooled RR (95% CI)
			Q(p)	I2 (%)
1. Comparison between CB-DOT and Family-based DOT
Successful treatment
All studies on all PTB	4	2880	0.21	33	0.99 [0.95, 1.04]
All cases(RCT)	3	2619	0.17	43	0.99 [0.94,1.03]
Cured treatment
All studies on all PTB	3	1233	0.39	0	1.09 [0.99,1,09]
All cases(RCT)	2	972	0.23	31	1.08 [0.97,1.20]
Completed treatment
All studies on all PTB	3	1233	0.55	0	0.93 [0.75,1.15]
All cases(RCT)	2	972	0.62	0	0.97 [0.791.20,]
Death
All studies on all PTB	3	1973	0.87	0	0.81 [0.63,1.04]
All cases(RCT)	2	1712	0.61	0	0.81 [0.63,1.05]
Failure
All studies on all PTB	3	1772	0.89	0	0.67 [0.13,3.47]
All cases(RCT)	2	1712	0.9	0	0.88 [0.12,6.40]
2. Comparison of Successful treatment between CB-DOT DOT and Workplace-based DOT
All PTB	2	1330	0.19	43	0.85 [0.79, 0.90]
New PTB	2	1240	0.2	39	0.84 [0.79, 0.90]
3. Comparison between CB-DOT and Self-administered treatment based on all studies on all PTB)
Successful treatment	3	534	0.69	0	1.13 [1.03, 1.24]
Cured treatment	2	225	0.46	0	1.24 [1.04, 1.48]
Completed treatment	2	225	0.36	0	0.72 [0.32, 1.60]
Death	2	225	0.65	0	1.02 [0.29, 3.60]
Failed treatment	2	225	0.95	0	1.19 [0.26, 5.50]